Risankizumab
Drug timelines are a Plus or Pro feature.
45 regulatory and trial events tracked for Risankizumab, covering 2017-07-06 to 2026-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]